Section I. Assisting the pharmacist in serving patients -- Section II. Inventory control -- Section III. Pharmaceutical calculations -- Section IV. Pharmacy operations -- Section V. Pharmacology -- Appendices -- Index.
The learning needs assessment project : improving service to persons with developmental disabilities & complex mental health needs in the central region of Nova Scotia
Introduction: Ethics in nursing : continuity and change -- 1. Nursing ethics : historical, cultural and professional perspectives -- 2. Nursing ethics - what do we mean by ’ethics’? -- 3. Becoming a nurse and member of the profession -- 4. Power and responsibility in nursing practice and management -- 5. Professional responsibility and accountability in nursing -- 6. Classical areas of controversy in nursing and biomedical ethics -- 7. Direct responsibility in nurse/patient relationships -- 8. Conflicting demands in nursing groups of patients -- 9. Ethics in healthcare management : research, evaluation and performance management -- 10. political ethics of healthcare : health policies and resource allocation -- 11. Corporate ethics in healthcare : strategic planning and ethical policy development -- 12. Making moral decisions and being able to justify our actions -- 13. relevance of moral theory : justifying our ethical policies.
Cover -- Half-title -- Title -- Copyright -- Contents -- Contributors -- 1 The vascular endothelium: structure and function -- INTRODUCTION -- ANGIOGENESIS -- Endothelial cell extracellular matrix attachments: the role of integrins -- Endothelial cell migration -- Cell-cell contacts -- Regulation of angiogenesis: a balance of angiostatic versus proangiogenic factors -- VASOREGULATION/ENDOTHELIAL REACTIVITY -- Nitric oxide -- Endothelins -- Prostacyclin (PGI2) -- Platelet activating factor (PAF) -- ENDOTHELIUM IN INFLAMMATION -- Selectins -- Integrins -- Immunoglobulin gene superfamily -- COAGULATION -- The procoagulant activity of the deranged endothelium -- Endothelial cells and fibrinolysis -- CONCLUSIONS -- REFERENCES -- 2 Vascular smooth muscle cells: structure and function -- STRUCTURE -- CONTRACTILE FUNCTION -- VASCULAR SMOOTH MUSCLE PROLIFERATION -- HOW ARE VSMCS STUDIED? -- ARE THERE DIFFERENT SUBTYPES OF VSMCS? -- ANGIOGENESIS AND ARTERIOGENESIS -- SUMMARY -- REFERENCES -- 3 Vascular haemodynamics -- INTRODUCTION -- LAPLACE'S LAW OF WALL TENSION -- NEWTONIAN FLUID -- SHEAR THINNING FLUID -- POISEUILLE FLOW -- BERNOULLI'S EQUATION -- YOUNG'S MODULUS AND PULSATILE FLOW -- MASS CONSERVATION -- REYNOLDS' NUMBER -- SHEAR STRESS AND PRESSURE -- FORCES ON A SINGLE TUBE GRAFT SYSTEM -- Case 1 - the cylindrical graft -- Case 2 - the windsock graft -- Case 3 - the curved graft -- CONCLUSION -- REFERENCES -- 4 Haemostasis - a clinician's perspective -- NORMAL HAEMOSTASIS -- EVOLUTION OF OUR UNDERSTANDING OF HAEMOSTASIS -- LIMITATIONS OF THE CASCADE MODEL -- COMPONENTS OF THE COAGULATION PATHWAY -- Introduction -- Co-factors and transport molecules (factors V, VIII, protein S and von Willebrand factor) -- Factor XI and the 'contact factors' -- Cell associated co-factors (tissue factor and thrombomodulin) -- Fibrinogen -- Factor XIII and thrombin-activatable .brinolysis inhibitor -- Plasma coagulation protease inhibitors (antithrombin-III and tissue factor pathway inhibitor) -- ENDOTHELIAL CELLS AND COAGULATION -- FIBRINOLYSIS -- THE PRESENT MODEL OF HAEMOSTASIS -- THE FUTURE -- SUGGESTED READING -- HISTORICAL REFERENCES -- 5 Hypercoagulability and vascular disease -- INTRODUCTION -- COAGULATION CASCADE -- INDIVIDUAL FACTORS -- Inherited thrombophilia defects -- HOMOCYSTEINE -- PREVALENCE AND RISK OF THROMBOPHILIA DEFECTS AND VENOUS DISEASE -- PREVALENCE AND RISK OF HOMOCYSTEINE AND VENOUS DISEASE -- PREVALENCE AND RISK OF THROMBOPHILIA DEFECTS AND ARTERIAL DISEASE -- THROMBOPHILIA AND FAILURE OF INTERVENTION IN PERIPHERAL VASCULAR DISEASE -- PREVALENCE AND RISK OF HYPERHOMOCYSTEINAEMIA IN ARTERIAL DISEASE -- HOMOCYSTEINE AND FAILURE OF INTERVENTION IN PERIPHERAL VASCULAR DISEASE -- THE PREVALENCE AND RISK OF HYPERFIBRINOGENAEMIA IN VASCULAR DISEASE -- SCREENING -- THERAPEUTIC OPTIONS -- HEPARIN -- WARFARIN -- ANTIPLATELET AGENTS -- Aspirin and dipyridamole -- Glycoprotein IIb/IIIa platelet receptor inhibitors -- Ticlodipine and clopidigrel -- Cilostazol, naftidrofuryl and pentoxifylline -- Thrombin inhibitors -- Folic acid -- OVERVIEW -- REFERENCES -- 6 The role of platelets in